BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Niemansburg SL, Teraa M, Hesam H, van Delden JJ, Verhaar MC, Bredenoord AL. Stem cell trials for cardiovascular medicine: ethical rationale. Tissue Eng Part A 2014;20:2567-74. [PMID: 24164351 DOI: 10.1089/ten.TEA.2013.0332] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Stoeklé HC, Ivasilevitch A, Marignac G, Hervé C. Creation and use of organoids in biomedical research and healthcare: the bioethical and metabioethical issues. Cell Adh Migr 2021;15:285-94. [PMID: 34706616 DOI: 10.1080/19336918.2021.1996749] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
2 Arjmand B, Abedi M, Arabi M, Alavi-Moghadam S, Rezaei-Tavirani M, Hadavandkhani M, Tayanloo-Beik A, Kordi R, Roudsari PP, Larijani B. Regenerative Medicine for the Treatment of Ischemic Heart Disease; Status and Future Perspectives. Front Cell Dev Biol 2021;9:704903. [PMID: 34568321 DOI: 10.3389/fcell.2021.704903] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
3 de Windt T, Niemansburg S, Vonk L, van Delden J, Roes K, Dhert W, Saris D, Bredenoord A. Ethics in musculoskeletal regenerative medicine; guidance in choosing the appropriate comparator in clinical trials. Osteoarthritis and Cartilage 2019;27:34-40. [DOI: 10.1016/j.joca.2018.08.022] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
4 van Rhijn-Brouwer FCC, Gremmels H, Fledderus JO, Schuurman AH, Bonte-Mineur F, Vonk MC, Voskuyl AE, de Vries-Bouwstra JK, Coert JH, Radstake TRDJ, van Laar JM, Verhaar MC; MANUS Study Group. A randomised placebo-controlled double-blind trial to assess the safety of intramuscular administration of allogeneic mesenchymal stromal cells for digital ulcers in systemic sclerosis: the MANUS Trial protocol. BMJ Open 2018;8:e020479. [PMID: 30127049 DOI: 10.1136/bmjopen-2017-020479] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
5 Teraa M, Gremmels H, Wijnand JGJ, Verhaar MC. Cell Therapy for Chronic Limb-Threatening Ischemia: Current Evidence and Future Directions. Stem Cells Transl Med 2018;7:842-6. [PMID: 30070050 DOI: 10.1002/sctm.18-0025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
6 Bredenoord AL, Clevers H, Knoblich JA. Human tissues in a dish: The research and ethical implications of organoid technology. Science 2017;355:eaaf9414. [DOI: 10.1126/science.aaf9414] [Cited by in Crossref: 126] [Cited by in F6Publishing: 126] [Article Influence: 25.2] [Reference Citation Analysis]
7 Dykstra JA, Facile T, Patrick RJ, Francis KR, Milanovich S, Weimer JM, Kota DJ. Concise Review: Fat and Furious: Harnessing the Full Potential of Adipose-Derived Stromal Vascular Fraction. Stem Cells Transl Med 2017;6:1096-108. [PMID: 28186685 DOI: 10.1002/sctm.16-0337] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 8.2] [Reference Citation Analysis]
8 Otto IA, Breugem CC, Malda J, Bredenoord AL. Ethical considerations in the translation of regenerative biofabrication technologies into clinic and society. Biofabrication 2016;8:042001. [PMID: 27716629 DOI: 10.1088/1758-5090/8/4/042001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
9 Madonna R, Van Laake LW, Davidson SM, Engel FB, Hausenloy DJ, Lecour S, Leor J, Perrino C, Schulz R, Ytrehus K, Landmesser U, Mummery CL, Janssens S, Willerson J, Eschenhagen T, Ferdinandy P, Sluijter JP. Position Paper of the European Society of Cardiology Working Group Cellular Biology of the Heart: cell-based therapies for myocardial repair and regeneration in ischemic heart disease and heart failure. Eur Heart J. 2016;37:1789-1798. [PMID: 27055812 DOI: 10.1093/eurheartj/ehw113] [Cited by in Crossref: 147] [Cited by in F6Publishing: 158] [Article Influence: 24.5] [Reference Citation Analysis]
10 Bredenoord AL, Mostert M, Isasi R, Knoppers BM. Data sharing in stem cell translational science: policy statement by the International Stem Cell Forum Ethics Working Party. Regenerative Medicine 2015;10:857-61. [DOI: 10.2217/rme.15.42] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
11 Vonk LA, de Windt TS, Slaper-Cortenbach IC, Saris DB. Autologous, allogeneic, induced pluripotent stem cell or a combination stem cell therapy? Where are we headed in cartilage repair and why: a concise review. Stem Cell Res Ther 2015;6:94. [PMID: 25976213 DOI: 10.1186/s13287-015-0086-1] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 6.3] [Reference Citation Analysis]
12 Lowenthal J, Sugarman J. Ethics and policy issues for stem cell research and pulmonary medicine. Chest 2015;147:824-34. [PMID: 25732448 DOI: 10.1378/chest.14-1696] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
13 Niemansburg SL, van Delden JJ, Dhert WJ, Bredenoord AL. Reconsidering the ethics of sham interventions in an era of emerging technologies. Surgery 2015;157:801-10. [DOI: 10.1016/j.surg.2014.12.001] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 3.1] [Reference Citation Analysis]
14 van Osch GJ, Burdick JA, Liu W. Emerging issues in translating laboratory experiments to applications for society. Tissue Eng Part A 2014;20:2547-8. [PMID: 25119481 DOI: 10.1089/ten.TEA.2014.0329] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
15 King NM, Perrin J. Ethical issues in stem cell research and therapy. Stem Cell Res Ther. 2014;5:85. [PMID: 25157428 DOI: 10.1186/scrt474] [Cited by in Crossref: 86] [Cited by in F6Publishing: 79] [Article Influence: 10.8] [Reference Citation Analysis]